Lilly Europe launch

Eli Lilly Says Trump Pricing Policy Will Affect Obesity Drug Launches in Europe

Eli Lilly targets European obesity drug launches by late 2026 via telehealth, citing U.S. pricing policies as a key factor in reimbursement negotiations and market strategy.